Prime Medicine, Inc. (PRME) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Prime Medicine, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -2.57x | -1.77x | -4.07x | -14.83x | -8.90x | -431.49x |
| P/B Ratio | 4.27x | 2.26x | 6.06x | 5.71x | 6.14x | 43.96x |
| P/S Ratio | 111.44x | 116.10x | 0.00x | 0.00x | 0.00x | 282.41x |
| Profitability | ||||||
| Gross Margin | -58.1% | 100.0% | 0.0% | 0.0% | 0.0% | 42.8% |
| Operating Margin | -4498.1% | -6787.4% | 0.0% | 0.0% | 0.0% | -17.9% |
| Net Margin | -4342.4% | -6566.6% | 0.0% | 0.0% | 0.0% | -65.5% |
| EBITDA Margin | -4226.2% | -6581.9% | 0.0% | 0.0% | 0.0% | -17.1% |
| Liquidity | ||||||
| Current Ratio | 4.84x | 5.58x | 2.53x | 11.10x | 4.67x | 2.75x |
| Quick Ratio | 4.84x | 5.58x | 2.53x | 11.10x | 4.67x | 2.75x |
| Leverage | ||||||
| Debt/Equity | 0.96x | 0.27x | 0.10x | 0.09x | 0.04x | 0.00x |
YoY = year-over-year change. Source: FMP..